Literature DB >> 871651

Effects of tamoxifen in relation to breast cancer.

V C Jordan.   

Abstract

Entities:  

Keywords:  Biology; Breast Cancer; Cancer; Diseases; Endocrine System; Estrogens; Family Planning; Fertility Agents; Hormone Antagonists--side effects; Hormones; Neoplasms; Physiology; Reproductive Control Agents; Tamoxifen--side effects; Tamoxifen--therapeutic use

Mesh：

Substances：

Year:  1977        PMID： 871651      PMCID： PMC1607295          DOI： 10.1136/bmj.1.6075.1534-d

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  Interactions of antiestrogens with human breast cancer in long-term tissue culture.

Authors:  M Lippman; G Bolan; K Huff
Journal:  Cancer Treat Rep       Date:  1976-10

2.  Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.

Authors:  V C Jordan
Journal:  Cancer Treat Rep       Date:  1976-10
  2 in total
  6 in total

1.  Effects of estrogen and estrus cycle on pharmacokinetics, absorption, and disposition of genistein in female Sprague-Dawley rats.

Authors:  Kaustubh H Kulkarni; Zhen Yang; Tao Niu; Ming Hu
Journal:  J Agric Food Chem       Date:  2012-08-03       Impact factor: 5.279

Review 2.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Concordant effects of aromatase inhibitors on gene expression in ER+ Rat and human mammary cancers and modulation of the proteins coded by these genes.

Authors:  Yan Lu; Ming You; Zara Ghazoui; Pengyuan Liu; Peter T Vedell; Weidong Wen; Ann M Bode; Clinton J Grubbs; Ronald A Lubet
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-25

Review 4.  Tamoxifen resistance in breast cancer.

Authors:  Minsun Chang
Journal:  Biomol Ther (Seoul)       Date:  2012-05       Impact factor: 4.634

5.  A nation-wide multicenter 10-year (1999-2008) retrospective clinical study of endocrine therapy for Chinese females with breast cancer.

Authors:  Can Zhou; Jian jun He; Jing Li; Jin hu Fan; Bin Zhang; Hong jian Yang; Xiao ming Xie; Zhong hua Tang; Hui Li; Jia yuan Li; Shu lian Wang; You lin Qiao; Rong Huang; Pin Zhang
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

6.  Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer.

Authors:  Rosaria Benedetti; Carmela Dell'Aversana; Tommaso De Marchi; Dante Rotili; Ning Qing Liu; Boris Novakovic; Serena Boccella; Salvatore Di Maro; Sandro Cosconati; Alfonso Baldi; Emma Niméus; Johan Schultz; Urban Höglund; Sabatino Maione; Chiara Papulino; Ugo Chianese; Francesco Iovino; Antonio Federico; Antonello Mai; Hendrik G Stunnenberg; Angela Nebbioso; Lucia Altucci
Journal:  Cancers (Basel)       Date:  2019-12-16       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.